GH Research PLC (GHRS)
11.25
-1.13
(-9.13%)
USD |
NASDAQ |
May 02, 16:00
11.25
0.00 (0.00%)
After-Hours: 20:00
GH Research Cash from Investing (Quarterly): -0.024M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.024M |
| September 30, 2023 | -0.008M |
| June 30, 2023 | -0.046M |
| March 31, 2023 | -54.02M |
| December 31, 2022 | -84.64M |
| September 30, 2022 | -0.015M |
| June 30, 2022 | -0.024M |
| March 31, 2022 | -0.01M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.019M |
| September 30, 2021 | -0.05M |
| June 30, 2021 | -0.014M |
| March 31, 2021 | -0.021M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-84.64M
Minimum
Dec 2022
--
Maximum
Mar 2020
-8.681M
Average
-0.017M
Median
Cash from Investing (Quarterly) Benchmarks
| Amarin Corp PLC | -71.00M |
| Jazz Pharmaceuticals PLC | 101.80M |
| Prothena Corp PLC | -1.512M |
| Iterum Therapeutics PLC | 13.52M |
| Mural Oncology PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -8.085M |
| Cash from Financing (Quarterly) | -0.041M |
| Free Cash Flow | -33.44M |
| Free Cash Flow Per Share (Quarterly) | -0.1559 |
| Free Cash Flow Yield | -5.71% |